Posted by sherlynjones > 2021-04-22 19:17 | Report Abuse

A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars. According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.